UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies

Advanced drug delivery reviews, 2016-08, Vol.103, p.5-19

2016

Link zum Volltext

Verfügbarkeit prüfen

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.572-580

2014

Link zum Volltext

Verfügbarkeit prüfen

Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters

PloS one, 2014-11, Vol.9 (11), p.e113146-e113146

2014

Link zum Volltext

Verfügbarkeit prüfen

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression

Scientific reports, 2015-06, Vol.5 (1), p.11511-11511, Article 11511

2015

Link zum Volltext

Verfügbarkeit prüfen

Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8 + T-Cells From HIV + Subjects Who Initiated cART at Different Time-Points After Acute Infection

Frontiers in immunology, 2018-10, Vol.9, p.2443-2443

2018

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

PloS one, 2019-09, Vol.14 (9), p.e0221653-e0221653

2019

Link zum Volltext

Verfügbarkeit prüfen

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART

Pathogens & immunity, 2021-10, Vol.6 (2), p.60-89

2021

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir–lamivudine as initial therapy in HIV‐1 infected, ARV‐naive patients, 48‐week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study

Journal of the International AIDS Society, 2017, Vol.20 (1), p.21678-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19554-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Suicidal Ideation Among Adults Re-engaging in HIV Care in Argentina

AIDS and behavior, 2019-12, Vol.23 (12), p.3427-3434

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes

Journal of clinical virology, 2022-02, Vol.147, p.105078-105078, Article 105078

2022

Link zum Volltext

Verfügbarkeit prüfen

Occupational exposure to hepatitis C virus

Medicina (Buenos Aires), 2007, Vol.67 (1), p.104

2007

Link zum Volltext

Verfügbarkeit prüfen

Mpox in people with advanced HIV infection: a global case series

The Lancet (British edition), 2023-03, Vol.401 (10380), p.939-949

2023

Link zum Volltext

Verfügbarkeit prüfen

La protección interamericana de la obligación alimentaria

Opinión jurídica, 2013-06, Vol.12 (23), p.133-150

2013

Link zum Volltext

Verfügbarkeit prüfen

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART

Antiviral research, 2010-08, Vol.87 (2), p.269-271

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of health-related quality of life and suicidal risk in adolescents: A cross-sectional study

Revista chilena de pediatria, 2018-06, Vol.89 (3), p.318

2018

Link zum Volltext

Verfügbarkeit prüfen

RADAR: a program for the prevention of suicide in adolescents in the region of Aysen, Chile, preliminary results

Revista chilena de pediatria, 2018-02, Vol.89 (1), p.145

2018

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/ritonavir en nuevas estrategias de tratamiento antirretroviral de inicio

Enfermedades infecciosas y microbiología clínica, 2014-11, Vol.32, p.7-11

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial

Journal of antimicrobial chemotherapy, 2019-02, Vol.74 (2), p.480-488

2019

Link zum Volltext

Verfügbarkeit prüfen

What to do Next? Second-line Antiretroviral Therapy

Current treatment options in infectious disease, 2014-06, Vol.6 (2), p.159-170

2014

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/ritonavir in new initial antiretroviral treatment strategies

Enfermedades infecciosas y microbiologia clinica, 2014-11, Vol.32 Suppl 3, p.7

2014

Link zum Volltext

Verfügbarkeit prüfen

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters: e113146

PloS one, 2014-11, Vol.9 (11)

2014

Link zum Volltext

Verfügbarkeit prüfen

LAS ESTRATEGIAS DE AFRONTAMIENTO Y SU RELACIÓN CON EL NIVEL DE BIENESTAR PSICOLÓGICO. UN ESTUDIO CON ADOLESCENTES DE NIVEL SOCIOECONÓMICO BAJO DE TUCUMÁN (ARGENTINA)

Anales de psicología (Murcia, Spain), 2005-01, Vol.21 (1), p.66

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression

Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8 + T-Cells From HIV + Subjects Who Initiated cART at Different Time-Points After Acute Infection

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART

Dolutegravir–lamivudine as initial therapy in HIV‐1 infected, ARV‐naive patients, 48‐week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study

Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study

Suicidal Ideation Among Adults Re-engaging in HIV Care in Argentina

Epidemiology of dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes

Occupational exposure to hepatitis C virus

Mpox in people with advanced HIV infection: a global case series

La protección interamericana de la obligación alimentaria

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART

Association of health-related quality of life and suicidal risk in adolescents: A cross-sectional study

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

RADAR: a program for the prevention of suicide in adolescents in the region of Aysen, Chile, preliminary results

Lopinavir/ritonavir en nuevas estrategias de tratamiento antirretroviral de inicio

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial

What to do Next? Second-line Antiretroviral Therapy

Lopinavir/ritonavir in new initial antiretroviral treatment strategies

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters: e113146

LAS ESTRATEGIAS DE AFRONTAMIENTO Y SU RELACIÓN CON EL NIVEL DE BIENESTAR PSICOLÓGICO. UN ESTUDIO CON ADOLESCENTES DE NIVEL SOCIOECONÓMICO BAJO DE TUCUMÁN (ARGENTINA)

Suchergebnisse filtern